Literature DB >> 24613022

Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.

Adam M Zahm1, Nicholas J Hand2, Daphne M Tsoucas3, Claire L Le Guen4, Robert N Baldassano5, Joshua R Friedman6.   

Abstract

BACKGROUND AND AIMS: Changes in intestinal microRNAs have been reported in adult patients with ulcerative colitis or Crohn's disease. The goal of this study was to identify changes in microRNA expression associated with colitis in children with inflammatory bowel disease.
METHODS: Rectal mucosal biopsies (n = 50) and blood samples (n = 47) were collected from patients with known or suspected inflammatory bowel disease undergoing endoscopy. Rectal and serum microRNA levels were profiled using the nCounter platform and the TaqMan low-density array platform, respectively. Significantly altered microRNAs were validated in independent sample sets via quantitative RT-PCR. In vitro luciferase reporter assays were performed in the human colorectal Caco-2 cell line to determine the effect of miR-192 on NOD2 expression.
RESULTS: Profiling of rectal RNA identified 21 microRNAs significantly altered between control, UC, and colonic CD sample groups. Nine of the ten microRNAs selected for validation were confirmed as significantly changed. Rectal miR-24 was increased 1.47-fold in UC compared to CD samples (p = 0.0052) and was the only microRNA altered between IBD subtypes. Three colitis-associated microRNAs were significantly altered in sera of disease patients and displayed diagnostic utility. However, no serum microRNAs were found to distinguish ulcerative colitis from Crohn's colitis. Finally, miR-192 inhibition did not affect luciferase reporter activity, suggesting that miR-192 does not regulate human NOD2.
CONCLUSION: This study has demonstrated that rectal and serum microRNAs are perturbed in pediatric inflammatory bowel disease. Future studies identifying targets of inflammatory bowel disease-associated microRNAs may lead to novel therapies.
Copyright © 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Circulating microRNA; Crohn's disease; Inflammatory bowel disease; MicroRNA; Serum microRNA; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 24613022      PMCID: PMC4146627          DOI: 10.1016/j.crohns.2014.02.012

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  45 in total

1.  MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia.

Authors:  Nicholas J Hand; Amber M Horner; Zankhana R Master; LaTasha A Boateng; Claire LeGuen; Marina Uvaydova; Joshua R Friedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-02       Impact factor: 2.839

2.  Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish.

Authors:  Ariel A Bazzini; Miler T Lee; Antonio J Giraldez
Journal:  Science       Date:  2012-03-15       Impact factor: 47.728

3.  Circulating MicroRNA in inflammatory bowel disease.

Authors:  Archanioti Paraskevi; George Theodoropoulos; Ioannis Papaconstantinou; Gerassimos Mantzaris; Nikolaos Nikiteas; Maria Gazouli
Journal:  J Crohns Colitis       Date:  2012-02-28       Impact factor: 9.071

4.  miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.

Authors:  Joel R Pekow; Urszula Dougherty; Reba Mustafi; Hongyan Zhu; Masha Kocherginsky; David T Rubin; Stephen B Hanauer; John Hart; Eugene B Chang; Alessandro Fichera; Loren J Joseph; Marc Bissonnette
Journal:  Inflamm Bowel Dis       Date:  2011-05-06       Impact factor: 5.325

5.  The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-κB activation.

Authors:  Erik B Wendlandt; Joel W Graff; Theresa L Gioannini; Anton P McCaffrey; Mary E Wilson
Journal:  Innate Immun       Date:  2012-04-20       Impact factor: 2.680

6.  Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.

Authors:  Zhen Bian; Limin Li; Jinglong Cui; Hongjie Zhang; Yuan Liu; Chen-Yu Zhang; Ke Zen
Journal:  J Pathol       Date:  2011-05-18       Impact factor: 7.996

7.  miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay.

Authors:  Sergej Djuranovic; Ali Nahvi; Rachel Green
Journal:  Science       Date:  2012-04-13       Impact factor: 47.728

8.  MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.

Authors:  Feng Wu; Michelle Zikusoka; Anil Trindade; Themistocles Dassopoulos; Mary L Harris; Theodore M Bayless; Steven R Brant; Shukti Chakravarti; John H Kwon
Journal:  Gastroenterology       Date:  2008-08-03       Impact factor: 22.682

9.  Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.

Authors:  Arie Levine; Anne Griffiths; James Markowitz; David C Wilson; Dan Turner; Richard K Russell; John Fell; Frank M Ruemmele; Thomas Walters; Mary Sherlock; Marla Dubinsky; Jeffrey S Hyams
Journal:  Inflamm Bowel Dis       Date:  2010-11-08       Impact factor: 5.325

10.  Long-term, efficient inhibition of microRNA function in mice using rAAV vectors.

Authors:  Jun Xie; Stefan L Ameres; Randall Friedline; Jui-Hung Hung; Yu Zhang; Qing Xie; Li Zhong; Qin Su; Ran He; Mengxin Li; Huapeng Li; Xin Mu; Hongwei Zhang; Jennifer A Broderick; Jason K Kim; Zhiping Weng; Terence R Flotte; Phillip D Zamore; Guangping Gao
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

View more
  28 in total

Review 1.  Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.

Authors:  Weiwei Jiang; Xuhang Li
Journal:  Mol Diagn Ther       Date:  2015-06       Impact factor: 4.074

Review 2.  Role of MiRNAs in Inflammatory Bowel Disease.

Authors:  Bo Cao; Xin Zhou; Jiaojiao Ma; Wei Zhou; Wanli Yang; Daiming Fan; Liu Hong
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

Review 3.  Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

Authors:  Ross John Porter; Caroline Andrews; Daniel Paul Brice; Scott Kenneth Durum; Mairi Hall McLean
Journal:  Inflamm Bowel Dis       Date:  2018-09-15       Impact factor: 5.325

4.  Pediatric eosinophilic esophagitis is associated with changes in esophageal microRNAs.

Authors:  Adam M Zahm; Calies Menard-Katcher; Alain J Benitez; Daphne M Tsoucas; Claire L Le Guen; Nicholas J Hand; Joshua R Friedman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-21       Impact factor: 4.052

5.  A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium.

Authors:  Georgios Koukos; Christos Polytarchou; Jess L Kaplan; Angelos Oikonomopoulos; David Ziring; Daniel W Hommes; Renaisa Wahed; Efi Kokkotou; Charalabos Pothoulakis; Harland S Winter; Dimitrios Iliopoulos
Journal:  Inflamm Bowel Dis       Date:  2015-05       Impact factor: 5.325

6.  Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute simian immunodeficiency virus infection of rhesus macaques.

Authors:  Lawrance C Chandra; Vinay Kumar; Workineh Torben; Curtis Vande Stouwe; Peter Winsauer; Angela Amedee; Patricia E Molina; Mahesh Mohan
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

7.  Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.

Authors:  Dániel Szűcs; Nóra Judit Béres; Réka Rokonay; Kriszta Boros; Katalin Borka; Zoltán Kiss; András Arató; Attila J Szabó; Ádám Vannay; Erna Sziksz; Csaba Bereczki; Gábor Veres
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

Review 8.  MicroRNAs: how many in inflammatory bowel disease?

Authors:  Jeremy S Schaefer
Journal:  Curr Opin Gastroenterol       Date:  2016-07       Impact factor: 3.287

Review 9.  Epigenetic regulation of pediatric and neonatal immune responses.

Authors:  Jennifer Bermick; Matthew Schaller
Journal:  Pediatr Res       Date:  2021-07-08       Impact factor: 3.756

Review 10.  Roles of microRNAs in inflammatory bowel disease.

Authors:  HyunTaek Jung; Jae Seok Kim; Keum Hwa Lee; Kalthoum Tizaoui; Salvatore Terrazzino; Sarah Cargnin; Lee Smith; Ai Koyanagi; Louis Jacob; Han Li; Sung Hwi Hong; Dong Keon Yon; Seung Won Lee; Min Seo Kim; Paul Wasuwanich; Wikrom Karnsakul; Jae Il Shin; Andreas Kronbichler
Journal:  Int J Biol Sci       Date:  2021-05-17       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.